Income Statement (TTM)
Appili Therapeutics Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Change (%) | -100.00 | ∞ | 0.00 | 0.00 | 0.00 | -100.00 | ∞ | 0.00 | 100.94 | 71.24 | -28.04 | 0.00 | -40.20 | -74.79 | -19.48 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | ||
| Cost Of Sales | |||||||||||||||||
| Change (%) | |||||||||||||||||
| % of Revenue | |||||||||||||||||
| Gross Operating Profit | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Change (%) | -100.00 | ∞ | 0.00 | 0.00 | 0.00 | -100.00 | ∞ | 0.00 | 100.94 | 71.24 | -28.04 | 0.00 | -40.20 | -74.79 | -19.48 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | ||
| SG&A | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| Change (%) | 3.69 | 12.64 | -5.31 | -8.69 | -7.04 | 2.78 | -0.45 | -1.24 | -4.05 | -19.66 | -7.54 | -7.21 | -4.64 | -6.08 | 5.75 | -4.27 | |
| % of Revenue | 2,418.25 | 404.38 | 382.89 | 349.62 | 325.01 | 1,383.87 | 1,366.68 | 652.57 | 306.17 | 393.44 | 365.07 | 582.15 | 2,168.71 | 2,848.43 | 2,726.88 | ||
| R&D | 4 | 6 | 24 | 21 | 16 | 6 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 6 |
| Change (%) | 77.92 | 265.56 | -12.11 | -24.56 | -62.70 | -40.38 | 4.13 | 6.20 | 21.06 | 17.94 | 2.32 | 14.03 | 16.04 | -0.70 | -0.85 | -14.46 | |
| % of Revenue | 1,822.59 | 1,697.12 | 1,491.67 | 1,125.35 | 419.77 | 1,084.42 | 1,151.65 | 693.81 | 477.85 | 679.51 | 774.81 | 1,503.47 | 5,921.76 | 7,292.15 | 6,237.47 | ||
| OpEx | 8 | 11 | 29 | 26 | 21 | 10 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 |
| Change (%) | 35.59 | 155.27 | -10.80 | -21.32 | -49.51 | -21.55 | 1.51 | 2.03 | 7.43 | -0.28 | -1.53 | 6.24 | 9.41 | -2.20 | 0.92 | -11.60 | |
| % of Revenue | 4,240.83 | 2,101.50 | 1,874.56 | 1,474.97 | 744.78 | 2,468.29 | 2,518.34 | 1,346.39 | 784.03 | 1,072.94 | 1,139.88 | 2,085.63 | 8,090.47 | 10,140.58 | 8,964.35 | ||
| Operating Income | -8 | -11 | -28 | -25 | -19 | -9 | -8 | -8 | -8 | -8 | -8 | -8 | -9 | -10 | -10 | -10 | -9 |
| Change (%) | 38.86 | 143.12 | -11.34 | -22.52 | -53.11 | -9.38 | -2.60 | 2.11 | 3.56 | -6.02 | 2.35 | 6.88 | 14.19 | 1.46 | 1.18 | -11.71 | |
| % of Revenue | -4,140.83 | -2,001.50 | -1,774.56 | -1,374.97 | -644.78 | -2,368.29 | -2,418.34 | -1,246.39 | -684.03 | -972.94 | -1,039.88 | -1,985.63 | -7,990.47 | -10,040.58 | -8,864.35 | ||
| Interest Expense | -0 | -0 | -0 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | -2 | -2 | -2 | -3 | -3 | -3 | -2 |
| Change (%) | 123.36 | 974.59 | 215.88 | 9.54 | 3.77 | 1.67 | -47.03 | 21.88 | 19.64 | 11.97 | 4.95 | 52.10 | 4.12 | 3.23 | 10.75 | -25.23 | |
| % of Revenue | -10.30 | -35.40 | -111.81 | -122.47 | -127.09 | -284.83 | -347.14 | -206.69 | -135.15 | -197.12 | -299.83 | -522.03 | -2,137.41 | -2,939.94 | -2,198.19 | ||
| Net Income | -8 | -11 | -27 | -25 | -20 | -11 | -10 | -9 | -8 | -8 | -5 | -4 | -4 | -4 | -4 | -3 | -2 |
| Change (%) | 40.92 | 151.90 | -6.17 | -20.08 | -47.52 | -5.88 | -6.79 | -8.40 | -7.81 | -31.61 | -29.17 | 0.96 | -6.11 | 10.38 | -33.66 | -12.78 | |
| % of Revenue | -3,787.60 | -1,924.95 | -1,806.18 | -1,443.45 | -757.57 | -2,765.90 | -2,533.63 | -1,162.36 | -464.23 | -456.96 | -461.35 | -724.40 | -3,171.41 | -2,613.12 | -2,279.26 | ||
Source: Capital IQ
